Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...
With a diverse drug portfolio and a robust pipeline of future drugs to market, this big pharma brand will play a major role ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback